USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
TWIN STAR MEDICAL
Address:
1000 Westgate Drive
St Paul, MN 55114-
Phone:
N/A
URL:
N/A
EIN:
141189283
DUNS:
076324156
Number of Employees:
3
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $992,837.00 5
SBIR Phase II $7,831,158.00 5

Award List:

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Richard L. Sutton
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase II
Award Amount:
$376,607.00
Agency:
HHS
Principal Investigator:
Richard L. Sutton
Abstract:
N/a

MANAGEMENT OF COMPARTMENT SYNDROME WITH ULTRAFILTRATION

Award Year / Program / Phase:
2001 / SBIR / Phase II
Award Amount:
$565,167.00
Agency:
HHS
Principal Investigator:
Rick M. Odland
Abstract:
DESCRIPTION (Verbatim from the Applicant's Abstract): Compartment Syndrome (CS) is a condition of high tissue pressure causing ischemia damaging muscles and nerves. It is known that in highly non-compliant tissues a small fluid volume decrease can produce a large pressure drop,… More

MANAGEMENT OF COMPARTMENT SYNDROME WITH ULTRAFILTRATION

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Rick M. Odland
Abstract:
DESCRIPTION (Verbatim from the Applicant's Abstract): Compartment Syndrome (CS) is a condition of high tissue pressure causing ischemia damaging muscles and nerves. It is known that in highly non-compliant tissues a small fluid volume decrease can produce a large pressure drop,… More

Reduction of Cerebral Edema using Ventricular Therapies

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$184,461.00
Agency:
HHS
Principal Investigator:
William V. Fowler
Abstract:
DESCRIPTION (provided by applicant): Cerebral edema after traumatic brain injury and severe stroke is a life-threatening condition that is refractory to conventional treatments in a significant population of patients. Current treatments (i.e. hyperventilation, osmotic diuretic(s) or hypothermia)… More

Treatment of Cerebral Edema Using Ventricular Therapy

Award Year / Program / Phase:
2005 / SBIR / Phase II
Award Amount:
$2,152,851.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Cerebral edema is associated with traumatic brain injury. The overall HYPOTHESIS of the proposed intervention is that free water removed from the brain following traumatic injury will minimize cerebral edema. Approach: The applicant proposes to complete… More

Hollow Fiber Catheter for Drug Delivery into the Brain

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$410,962.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Neurodegenerative and malignant diseases of the central nervous system (CNS) affect millions of Americans. These diseases are often devastating and difficult to treat and drug delivery remains a significant impediment . Direct infusion of drugs into the brain… More

Treatment of Cerebral Edema Using Ventricular Therapy

Award Year / Program / Phase:
2010 / SBIR / Phase II
Award Amount:
$2,945,581.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant):     Cerebral edema is arguably the most serious complication of severe traumatic brain injury (TBI). The central HYPOTHESIS is that increasing osmolality of cerebrospinal fluid (CSF) will move free water out of tissue into the ventricles where… More

Hollow Fiber Catheter for Drug Delivery into the Prostate

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$397,414.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Significance: Benign Prostatic Hyperplasia (BPH) will become an increasing burden on economic resources with the aging population. Surgical treatment is well established and has provided satisfactory results in 60 - 80% of men. However, it has been associated… More

Hollow Fiber Catheter for Drug Delivery into the Prostate

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$1,790,952.00
Agency:
HHS
Principal Investigator:
Jim Stice – 612-382-0888
Abstract:
DESCRIPTION (provided by applicant): The significance of the proposed research is based on the growing demand for healthcare resources to treat and manage prostatic disease, particularly benign prostatic hyperplasia (BPH) and cancer. Both the incidence andcost of treatment for BPH, and its… More